Ani Pharmaceuticals ANIP
NASDAQ ANIP
$72.18 -0.78 (-1.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ani Pharmaceuticals (ANIP) Cash & Current Investments (2010 - 2026)

Updated

Ani Pharmaceuticals (ANIP) recorded Cash & Current Investments of $360.21 million in Q2 2026, up 65.4% from $217.83 million a year earlier and up 15.8% from the prior quarter.

Analysis

Ani Pharmaceuticals (ANIP) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Ani Pharmaceuticals reported Cash & Current Investments of $285.59 million, up 97.1% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 105.1% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $144.89 million in FY2024 (-34.5%), $221.12 million in FY2023 (+358.5%), $48.23 million in FY2022 (-51.9%) and $100.3 million in FY2021.
  • The Q2 2026 figure is the highest quarterly Cash & Current Investments in data going back to Q2 2010.
  • On a year-over-year basis, Cash & Current Investments has increased for four consecutive quarters, with growth averaging 31.0% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 358.5% in Q4 2023, against a decline of 51.9% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $311.18 million (Q1 2026), $285.59 million (Q4 2025) and $262.61 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Ani Pharmaceuticals 1.72 Bn 502.13 Mn 165.89 Mn 360.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 360.21 Mn
Mar 31, 2026 311.18 Mn
Dec 31, 2025 285.59 Mn
Sep 30, 2025 262.61 Mn
Jun 30, 2025 217.83 Mn
Mar 31, 2025 149.80 Mn
Dec 31, 2024 144.89 Mn
Sep 30, 2024 144.98 Mn
Jun 30, 2024 240.11 Mn
Mar 31, 2024 228.60 Mn
Dec 31, 2023 221.12 Mn
Sep 30, 2023 193.08 Mn
Jun 30, 2023 161.71 Mn
Mar 31, 2023 67.76 Mn
Dec 31, 2022 48.23 Mn
Sep 30, 2022 56.28 Mn
Jun 30, 2022 63.39 Mn
Mar 31, 2022 76.91 Mn
Dec 31, 2021 100.30 Mn
Sep 30, 2021 15.25 Mn
API Access

Ani Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ANIP&period=max&api_key=YOUR_API_KEY